vs

Side-by-side financial comparison of PUMA BIOTECHNOLOGY, INC. (PBYI) and Smart Sand, Inc. (SND). Click either name above to swap in a different company.

Smart Sand, Inc. is the larger business by last-quarter revenue ($86.0M vs $75.5M, roughly 1.1× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -5.8%). Smart Sand, Inc. produced more free cash flow last quarter ($20.4M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 1.8%).

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

Sand 9 is a fabless Micro-electromechanical system (MEMS) company based in Cambridge, Massachusetts. Sand 9 developed a piezoelectric MEMS resonator to serve as an alternative for quartz timing devices in applications such as smart phones, low-power wireless devices, and communications infrastructure equipment.

PBYI vs SND — Head-to-Head

Bigger by revenue
SND
SND
1.1× larger
SND
$86.0M
$75.5M
PBYI
Growing faster (revenue YoY)
PBYI
PBYI
+33.5% gap
PBYI
27.7%
-5.8%
SND
More free cash flow
SND
SND
$6.0M more FCF
SND
$20.4M
$14.4M
PBYI
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
1.8%
SND

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PBYI
PBYI
SND
SND
Revenue
$75.5M
$86.0M
Net Profit
$1.2M
Gross Margin
69.3%
13.0%
Operating Margin
22.7%
-3.1%
Net Margin
1.4%
Revenue YoY
27.7%
-5.8%
Net Profit YoY
-68.5%
EPS (diluted)
$0.26
$0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PBYI
PBYI
SND
SND
Q4 25
$75.5M
$86.0M
Q3 25
$54.5M
$92.8M
Q2 25
$52.4M
$85.8M
Q1 25
$46.0M
$65.6M
Q4 24
$59.1M
$91.4M
Q3 24
$80.5M
$63.2M
Q2 24
$47.1M
$73.8M
Q1 24
$43.8M
$83.1M
Net Profit
PBYI
PBYI
SND
SND
Q4 25
$1.2M
Q3 25
$8.8M
$3.0M
Q2 25
$5.9M
$21.4M
Q1 25
$3.0M
$-24.2M
Q4 24
$3.7M
Q3 24
$20.3M
$-98.0K
Q2 24
$-4.5M
$-430.0K
Q1 24
$-4.8M
$-216.0K
Gross Margin
PBYI
PBYI
SND
SND
Q4 25
69.3%
13.0%
Q3 25
77.7%
16.1%
Q2 25
76.5%
10.4%
Q1 25
77.1%
4.2%
Q4 24
76.4%
14.7%
Q3 24
63.9%
10.3%
Q2 24
77.4%
17.7%
Q1 24
75.5%
14.2%
Operating Margin
PBYI
PBYI
SND
SND
Q4 25
22.7%
-3.1%
Q3 25
17.6%
5.8%
Q2 25
12.7%
-0.1%
Q1 25
8.7%
-10.8%
Q4 24
22.6%
3.9%
Q3 24
27.4%
-7.8%
Q2 24
-4.6%
4.8%
Q1 24
-5.3%
0.9%
Net Margin
PBYI
PBYI
SND
SND
Q4 25
1.4%
Q3 25
16.2%
3.2%
Q2 25
11.2%
24.9%
Q1 25
6.5%
-37.0%
Q4 24
4.1%
Q3 24
25.2%
-0.2%
Q2 24
-9.6%
-0.6%
Q1 24
-11.0%
-0.3%
EPS (diluted)
PBYI
PBYI
SND
SND
Q4 25
$0.26
$0.03
Q3 25
$0.17
$0.08
Q2 25
$0.12
$0.54
Q1 25
$0.06
$-0.62
Q4 24
$0.40
$0.10
Q3 24
$0.41
$0.00
Q2 24
$-0.09
$-0.01
Q1 24
$-0.10
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PBYI
PBYI
SND
SND
Cash + ST InvestmentsLiquidity on hand
$97.5M
$22.6M
Total DebtLower is stronger
$22.7M
$15.0M
Stockholders' EquityBook value
$130.3M
$239.7M
Total Assets
$216.3M
$340.0M
Debt / EquityLower = less leverage
0.17×
0.06×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PBYI
PBYI
SND
SND
Q4 25
$97.5M
$22.6M
Q3 25
$94.4M
$5.1M
Q2 25
$96.0M
$4.3M
Q1 25
$93.2M
$5.1M
Q4 24
$101.0M
$1.6M
Q3 24
$96.7M
$7.2M
Q2 24
$96.8M
$6.3M
Q1 24
$107.2M
$4.6M
Total Debt
PBYI
PBYI
SND
SND
Q4 25
$22.7M
$15.0M
Q3 25
$34.0M
$14.3M
Q2 25
$45.3M
$23.5M
Q1 25
$56.7M
$13.7M
Q4 24
$68.0M
$14.7M
Q3 24
$79.3M
$15.7M
Q2 24
$90.7M
$17.1M
Q1 24
$102.0M
$25.5M
Stockholders' Equity
PBYI
PBYI
SND
SND
Q4 25
$130.3M
$239.7M
Q3 25
$115.3M
$239.9M
Q2 25
$104.7M
$240.5M
Q1 25
$97.1M
$219.9M
Q4 24
$92.1M
$243.8M
Q3 24
$71.1M
$243.6M
Q2 24
$48.5M
$242.9M
Q1 24
$51.0M
$242.5M
Total Assets
PBYI
PBYI
SND
SND
Q4 25
$216.3M
$340.0M
Q3 25
$202.9M
$343.1M
Q2 25
$194.9M
$345.8M
Q1 25
$196.2M
$326.9M
Q4 24
$213.3M
$341.5M
Q3 24
$220.7M
$335.8M
Q2 24
$205.0M
$341.8M
Q1 24
$214.1M
$349.3M
Debt / Equity
PBYI
PBYI
SND
SND
Q4 25
0.17×
0.06×
Q3 25
0.30×
0.06×
Q2 25
0.43×
0.10×
Q1 25
0.58×
0.06×
Q4 24
0.74×
0.06×
Q3 24
1.12×
0.06×
Q2 24
1.87×
0.07×
Q1 24
2.00×
0.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PBYI
PBYI
SND
SND
Operating Cash FlowLast quarter
$14.4M
$22.4M
Free Cash FlowOCF − Capex
$14.4M
$20.4M
FCF MarginFCF / Revenue
19.1%
23.7%
Capex IntensityCapex / Revenue
0.0%
2.3%
Cash ConversionOCF / Net Profit
18.99×
TTM Free Cash FlowTrailing 4 quarters
$41.7M
$32.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PBYI
PBYI
SND
SND
Q4 25
$14.4M
$22.4M
Q3 25
$9.7M
$18.2M
Q2 25
$14.1M
$-5.1M
Q1 25
$3.6M
$8.7M
Q4 24
$15.6M
$1.0M
Q3 24
$11.0M
$5.8M
Q2 24
$1.0M
$14.9M
Q1 24
$11.2M
$-3.9M
Free Cash Flow
PBYI
PBYI
SND
SND
Q4 25
$14.4M
$20.4M
Q3 25
$9.7M
$14.8M
Q2 25
$14.1M
$-7.8M
Q1 25
$3.6M
$5.2M
Q4 24
$15.6M
$-840.0K
Q3 24
$11.0M
$3.7M
Q2 24
$1.0M
$13.5M
Q1 24
$-5.5M
FCF Margin
PBYI
PBYI
SND
SND
Q4 25
19.1%
23.7%
Q3 25
17.7%
15.9%
Q2 25
26.8%
-9.1%
Q1 25
7.7%
7.9%
Q4 24
26.4%
-0.9%
Q3 24
13.7%
5.8%
Q2 24
2.1%
18.3%
Q1 24
-6.6%
Capex Intensity
PBYI
PBYI
SND
SND
Q4 25
0.0%
2.3%
Q3 25
0.0%
3.6%
Q2 25
0.0%
3.1%
Q1 25
0.1%
5.4%
Q4 24
0.0%
2.1%
Q3 24
0.0%
3.4%
Q2 24
0.0%
1.8%
Q1 24
0.0%
2.0%
Cash Conversion
PBYI
PBYI
SND
SND
Q4 25
18.99×
Q3 25
1.10×
6.05×
Q2 25
2.41×
-0.24×
Q1 25
1.21×
Q4 24
0.28×
Q3 24
0.54×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PBYI
PBYI

Segment breakdown not available.

SND
SND

Sand$85.1M99%
Smart Systems Segment$980.0K1%

Related Comparisons